[Event Report] Second Forum: The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems (September 13, 2018)
date : 10/2/2018
Tags: Future of the Health Care System, Innovation and Sustainability
HGPI convened the Second Forum “The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems” on September 13, 2018.
Based on the issues raised at the preparatory meeting “Rebalancing Healthcare Systems: Innovation and Sustainability Series – Issues Identified from the Trial Introduction of Cost-Effectiveness Assessment” held on May 31, we identified three key themes (technical issues, issues for institutionalization, and public understanding) to be discussed in FY2018 and have been conducting a series of forums.
In this meeting, a roundtable discussion on HTA implementation was held with experts from industry, government, academia, and civil society. The discussions included policy functions required for the future implementation of Cost-Effectiveness Assessment, as well as its impact on the current healthcare and drug pricing systems.
The next forum is scheduled as follows:
- The Third Forum (November): Public Understanding
– Increasing Public Awareness and Understanding on the Impacts and Benefits of Cost-Effectiveness Assessment –
Organizer: HGPI
Participants: Policymakers, representatives from the government, academia and private sectors
Opening (Explanatory introduction)
- Ryoji Noritake (President, HGPI)
Roundtable Discussions “The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems”
Roundtable Speakers (Titles omitted, in Japanese syllabary order)
- Shunya Ikeda (Professor, Graduate School of Medicine/Public Health, International University of Health and Welfare)
- Yoshie Onishi (Director, Japan Operations, Creativ-Ceutical K.K.)
- Kosuke Kato (Managing Director, Edwards Lifesciences Limited)
- Isao Kamae (Project Professor, Graduate School of Public Policy, the University of Tokyo).
- Keiji Kono (Senior Vice President, Global Health Policy, External Affairs, Chugai Pharmaceutical Co., Ltd.)
- Shigekazu Komoto (Planning Officer, Medical Economics Division, Health Insurance Bureau, Ministry of Health, Labour and Welfare (MHLW))
- Naokazu Saito (Chief, Policy Intelligence Division, Integrated Market Access Department, Janssen Pharmaceutical K.K.)
- Hiroyuki Sakamaki (Professor, School of Management, Tokyo University of Science)
- Naomi Sakurai (President, Cancer Solutions Co., Ltd.)
- Tomoyuki Takura (Project Professor, Department of Healthcare Economics and Health Policy, Graduate School of Medicine and Faculty of Medicine, the University of Tokyo)
- Toshio Nagase (Director, Government Affairs, Gilead Science K.K.)
- Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University)
- Yoshiyuki Majima (President, Pancreatic Cancer Action Network Japan)
Moderator
- Joji Sugawara (Associate, HGPI)
Since 2016, HGPI has conducted a series of expert meetings entitled “Rebalancing Healthcare Systems: Innovation and Sustainability” to facilitate open discussions on HTA. Throughout these meetings, we have worked to identify the issues and to provide policy recommendations. For the past activities, please refer to the “Activity Report – Special Edition on Innovation and Sustainability” (attached below).
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] HGPI Planetary Health Policy Team Joins Call for Global Fossil Fuel Non-proliferation Treaty (October 18, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-03-04
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Issues Surrounding and Necessary Measures Against Obesity Disease” (February 2, 2024)
-
2024-03-05
[HGPI Policy Column] (No.41) – From the Mental Health Project Team – Mental Health Policy in Japan – History and Future Policy Topics (Part 1 of HGPI Activities for Mental Health and Domestic Policy History)
-
2024-03-18
[Registration Open] International Symposium “Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (April 9, 2024)
-
2024-03-22
[Registration Open] (Hybrid Format) The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)
-
2024-03-26
[Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)